Skip to main content
OncoTargets and Therapy logoLink to OncoTargets and Therapy
. 2019 Oct 25;12:8807. doi: 10.2147/OTT.S235000

Synergistic Effect Of A Retinoid X Receptor-Selective Ligand Bexarotene And Docetaxel In Prostate Cancer [Corrigendum]

PMCID: PMC6820567  PMID: 31695435

Shen D, Wang H, Zheng Q, et al. Onco Targets Ther. 2019;12:7877–7886.

Upon reviewing the article, the authors noticed an error in two of the authors name (page 7877). The correct author names are Liqun Xia and Gonghui Li.

The authors apologize for this error.


Articles from OncoTargets and therapy are provided here courtesy of Dove Press

RESOURCES